Altamira Therapeutics Ltd - Company Profile
Powered by 
All the data and insights you need on Altamira Therapeutics Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Altamira Therapeutics Ltd Strategy Report
- Understand Altamira Therapeutics Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Altamira Therapeutics Ltd (Altamira Therapeutics) formerly Auris Medical Holding Ltd, is a clinical-stage biopharmaceutical company with a focus on neurotology and CNS disorders. The company’s pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, post-acute inner ear tinnitus, Vertigo, tinnitus, sudden loss of hearing, antipsychotic-induced weight gain, somnolence, airborne allergens and viruses. It has research collaboration and licensing agreements with Biotechnology companies including Xigen and Inserm. Auris Medical is headquartered in Hamilton, Bermuda.
Headquarters
Bermuda
Address
Clarendon House, 2 Church Street, Hamilton, 6300
Website
aurismedical.com
Telephone
41 61 2011350
No of Employees
18
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
CYTO (NASD)
Revenue (0 vs)
$320,200
EPS
XYZ
Net Income (2022)
XYZ
85.4%
(2022 vs 2021)
Market Cap*
$3.5M
Net Profit Margin (2021)
XYZ
67.5%
(2022 vs 2021)
* As of and is in US$
Altamira Therapeutics Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Bentrio | Keyzilen |
| Pipeline | Sonsuvi |
| AM-401 | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In July, the company collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for cardiac regeneration. |
| 2022 | Contracts/Agreements | In June, the company announced that it has entered into marketing and distribution agreements in Pakistan and Egypt for Bentrio nasal spray for protection against airborne viruses and allergens. |
| 2022 | New Products/Services | In November, the company launched Bentrio in Hong Kong with its partner Nuance Pharma. |
Competitor Comparison
| Key Parameters | Altamira Therapeutics Ltd | Aevis Victoria SA | Autifony Therapeutics Ltd | Oricula Therapeutics LLC | Oticon Switzerland |
|---|---|---|---|---|---|
| Headquarters | Bermuda | Switzerland | United Kingdom | United States of America | Switzerland |
| City | Hamilton | Fribourg | Stevenage | Wilmington | - |
| State/Province | - | - | England | Delaware | - |
| No. of Employees | 18 | 4,033 | - | - | - |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Thomas Meyer | Chairman; Chief Executive Officer | Executive Board | 2003 | 55 |
| Covadonga Paneda | Chief Operating Officer | Senior Management | 2023 | 49 |
| Samuel A. Wickline | Chief Scientific Officer | Senior Management | 2021 | 69 |
| Marcel Gremaud | Chief Financial Officer | Senior Management | 2021 | 65 |
| Calvin W. Roberts | Director | Non Executive Board | 2015 | 69 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward